Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Low Volatility Stocks to Invest In Right Now

In this article, we will list the 5 Best Low Volatility Stocks to Invest In Right Now. Please visit 8 Best Low Volatility Stocks to Invest In Right Now if you would like to see the extended list and the methodology behind it.

5. The Procter & Gamble Company (NYSE:PG)

The Procter & Gamble Company (NYSE:PG) is one of the best low volatility stocks to invest in right now. The Procter & Gamble Company (NYSE:PG) announced financial results for fiscal Q3 2026 on April 24, reporting net sales of $21.2 billion, reflecting a growth of 7% compared to the prior year. Organic sales rose 3% compared to the previous year, excluding the impacts of foreign exchange and acquisitions and divestitures. The company also reported that the diluted net earnings per share were $1.63, up 6% versus the prior year and driven primarily by a gain from the dissolution of the Glad joint venture business. In addition, core earnings per share reached $1.59, up 3% compared to the previous year.

The Procter & Gamble Company (NYSE:PG) further reported that it returned $3.2 billion of cash to shareholders through $2.5 billion of dividend payments and over $600 million of share repurchases, with the dividend increase announced earlier in the month marking the company’s 70th consecutive year of dividend growth. It also marked the 136th consecutive year that The Procter & Gamble Company (NYSE:PG) has paid a dividend since its incorporation in 1890.

The Procter & Gamble Company (NYSE:PG) provides branded consumer packaged goods to consumers across the globe. Its operations are divided into Fabric & Home Care, Grooming, Beauty, Health Care, Feminine & Family Care, and Baby. The company boasts a strong portfolio of brands, which includes reputable names such as Head & Shoulders, Pantene, Old Spice, Olay, Herbal Essences, Safeguard, Tide, Always, Venus, Oral-B, Ariel, Crest, Tampax, and others.

4. Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson (NYSE:JNJ) is one of the best low volatility stocks to invest in right now. On April 24, Johnson & Johnson (NYSE:JNJ) announced that it entered into a definitive agreement to acquire Atraverse Medical, Inc., which is a privately-held medical device company pioneering next-generation left-heart access and radiofrequency (RF) technology. The company reported that Atraverse Medical’s HOTWIRE™ Transseptal Access System is already used in around 3,000 clinical procedures, and holds the status of an FDA-cleared RF guidewire and generator system designed for increased confidence and control when accessing the left atrium.

Management stated that the planned acquisition would bolster Johnson & Johnson’s (NYSE:JNJ) portfolio of cardiac ablation solutions by bringing electrophysiologists innovative tools for the treatment of patients with atrial fibrillation and other cardiac arrhythmias. The financial terms of the transaction are not being disclosed, and the company expects the transaction to close in the second quarter of 2026, subject to customary closing conditions.

Johnson & Johnson (NYSE:JNJ) develops, manufactures, and sells products in the healthcare field. The company operates through two segments: Innovative Medicine and MedTech. The Innovative Medicine segment focuses on various therapeutic areas, including oncology, infectious diseases, immunology, cardiovascular and metabolic diseases, and others. The MedTech segment includes an elaborate range of medical devices and products used in cardiovascular intervention, orthopedics, interventional solutions, surgery, and vision fields.

3. Eli Lilly and Company (NYSE:LLY)

Eli Lilly and Company (NYSE:LLY) is one of the best low volatility stocks to invest in right now. On April 24, Reuters reported that, according to analysts citing IQVIA data, Eli Lilly and Company’s (NYSE:LLY) newly launched oral weight loss drug, branded as Foundayo, was prescribed 3,707 times in the United States in the second week following its launch earlier in the month. The pill had 1,390 prescriptions in its first week of launch. Reuters provided additional perspective in the context of Eli Lilly and Company’s (NYSE:LLY) rival Novo ​Nordisk’s Wegovy pill. It reported that Wegovy has been on the market since January and had 3,071 prescriptions in its first week, followed by 18,410 prescriptions in the second week.

RBC Capital Markets analyst Trung Huynh stated that although they believe comparisons made early into the launch “should be considered immaterial, Foundayo’s uptake this week is likely to be ​received negatively”. Reuters also reported that J.P. Morgan analyst Chris Schott stated that the landscape represents a relatively slower ramp compared to oral Wegovy, which is not surprising, given the pill’s advantages in time to market and brand ​recognition.

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies.

2. UnitedHealth Group Incorporated (NYSE:UNH)

UnitedHealth Group Incorporated (NYSE:UNH) is one of the best low volatility stocks to invest in right now. On April 23, TD Cowen lifted the price target on UnitedHealth Group Incorporated (NYSE:UNH) to $337 from $311, maintaining a Hold rating on the shares and noting that it reported better than expected results. The firm thus raised estimates and multiples to bring to light an improved view of both FY26 and FY27 margin recovery.

In a separate development, UnitedHealth Group Incorporated (NYSE:UNH) announced on April 24 that over half of its previous authorization volume will be included in an industry-wide effort to standardize submission requirements for electronic prior authorization. It added that the number will advance to over 70% by the end of 2026, and marks the next phase of the company’s efforts to modernize and simplify prior authorization for care providers. It is also aimed at helping patients access safe and evidence-based care more quickly and easily, while simultaneously preserving important clinical safeguards. UnitedHealth Group Incorporated (NYSE:UNH) stated that the new standardized documentation process will apply across the company’s commercial, Medicare Advantage, and Medicaid offerings.

UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments.

1. Mastercard Incorporated (NYSE:MA)

Mastercard Incorporated (NYSE:MA) is one of the best low volatility stocks to invest in right now. On April 24, Truist cut the price target on Mastercard Incorporated (NYSE:MA) to $590 from $611, reaffirming a Buy rating on the shares. The rating update came as part of a broader research note previewing fiscal Q1 results for the Payments and Capital Markets names. The firm told investors in a research note that the setup feels mostly positive, as results of the US Banks point to volume upside for the payments group, growth in consumer spending has accelerated so far throughout 2026, and valuations have reset lower following recent underperformance. However, Truist added that investors should choose wisely and avoid stocks where there is potential for negative revisions.

Mastercard Incorporated (NYSE:MA) also received a rating update from BMO Capital on April 21. The firm initiated coverage of the stock with an Outperform rating and set a $605 price target. It told investors that despite disintermediation narratives from digital currencies and alternative railways, the firm considers Mastercard Incorporated (NYSE:MA) multi-railway strategy as expanding its moat and positioning the company as “the orchestration layer across all rails”.

Mastercard Incorporated (NYSE:MA) is a technology company that provides payment solutions for developing and implementing debit, credit, prepaid, commercial, and payment programs via its brands. Its portfolio includes Mastercard, Cirrus, and Maestro. The company also offers intelligence and cyber solutions.

While we acknowledge the potential of MA to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than MA and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.